Skip to main content

Biosimilars

Featured Article
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of…

Insights

In this blog, Russel J Spjut, owner of Formulary Intel Consulting, discusses how biosimilars have delivered a false hope of price reductions comparable to generic drugs.

Interactive Features

Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Back to Top